|
Philadelphia on Longevity Research
(Saturday October 28 2006)
 | A Philadelphia Magazine article from earlier this year starts out in a similar vein to the recent New York Magazine piece on calorie restriction, but becomes more astute closer to the end: "While much of anti-aging research and its recent genetic breakthroughs is closely related to well-heralded advances in diseases like cancer or Alzheimer's, the field was something of a scientific stepchild for decades. That's partly a result of our own attitudes, our acceptance of what we see as the depressing but unavoidable course of nature. Ten more heart-healthy years? Sign us up. A 'cure' for aging? That's just silly. Absent a public push for an anti-aging pill, there's been no billion-dollar incentive for the pharmaceutical industry to drill down on anti-aging efforts the way it does on age-related disease." Therein lies the real problem, the root of slow progress - and the reason I consider advocacy to be a worthwhile activity. |
|
